IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Lonza Reports Rise in First-Half Profits

11:29 PM MDT | July 22, 2010 | Deepti Ramesh

Lonza has recorded a 14.4% rise in first-half profits, to SF135 million ($130 million), compared to the year-ago period, and Ebitda increased by 3%, to SF309 million. Sales however decreased by 2%, to SF1.3 billion, mainly due to an expectedly weak first quarter in custom manufacturing, Lonza says. The Life Science Ingredients business recorded a 5.9% increase in sales in the first half, to SF536 million, compared with the year-ago period, and Ebit for the business increased by 17.4% to SF81 million. Volumes recovered in almost all end-markets except agchems...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa